Literature DB >> 11233367

Endurance and the ACE I/D polymorphism.

D R Woods1, D Brull, H E Montgomery.   

Abstract

A variant of the angiotensin-converting enzyme (ACE) gene, which we all carry, is known as the insertion, or I allele, due to the presence of a 287 base pair DNA fragment. This variant, or polymorphism, is associated with reduced levels of serum and tissue ACE. This intriguing polymorphism has been associated with various physiological and pathological states from diabetic renal disease to coronary heart disease. There have been conflicting reports regarding its association with some aspects of enhanced endurance performance in elite athletes. This review aims to examine the evidence for and against an association of the I allele with endurance and highlight some of the possible mechanism that might be involved. It is concluded that an association seems likely and that it is probably due to a local muscle effect rather than a central cardiorespiratory mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11233367

Source DB:  PubMed          Journal:  Sci Prog        ISSN: 0036-8504            Impact factor:   2.774


  12 in total

1.  Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

Authors:  Christy S Carter; Leanne Groban
Journal:  Aging health       Date:  2008-02-01

2.  Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes.

Authors:  Aldo Matos Costa; António José Silva; Nuno Garrido; Hugo Louro; Daniel Almeida Marinho; Mário Cardoso Marques; Luiza Breitenfeld
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

3.  The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype.

Authors:  David Woods; Julie Sanders; Alun Jones; Emma Hawe; Peter Gohlke; Steve E Humphries; John Payne; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2003-11-01       Impact factor: 3.078

4.  The ACE gene insertion/deletion polymorphism and elite endurance swimming.

Authors:  Georgios Tsianos; Julie Sanders; Sukhbir Dhamrait; Steve Humphries; Stan Grant; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2004-05-08       Impact factor: 3.078

5.  Genetic test for the personalization of sport training.

Authors:  Zakira Naureen; Marco Perrone; Stefano Paolacci; Paolo Enrico Maltese; Kristjana Dhuli; Danjela Kurti; Astrit Dautaj; Roberta Miotto; Arianna Casadei; Bernard Fioretti; Tommaso Beccari; Francesco Romeo; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09

Review 6.  Keeping pace with ACE: are ACE inhibitors and angiotensin II type 1 receptor antagonists potential doping agents?

Authors:  Pei Wang; Matthew N Fedoruk; Jim L Rupert
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

7.  Biomechanical muscle properties and angiotensin-converting enzyme gene polymorphism: a model-based study.

Authors:  Heiko Wagner; Sigrid Thaller; Regine Dahse; Martin Sust
Journal:  Eur J Appl Physiol       Date:  2006-09-28       Impact factor: 3.346

8.  The angiotensin-converting enzyme insertion/deletion polymorphism rs4340 associates with habitual physical activity among European American adults.

Authors:  Michael Bruneau; Theodore J Angelopoulos; Paul Gordon; Niall Moyna; Paul Visich; Robert Zoeller; Rick Seip; Stephen Bilbie; Paul Thompson; Joseph Devaney; Heather Gordish-Dressman; Eric Hoffman; Linda S Pescatello
Journal:  Mol Genet Genomic Med       Date:  2017-07-02       Impact factor: 2.183

9.  A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD.

Authors:  Dinesh Shrikrishna; Rebecca J Tanner; Jen Y Lee; Amanda Natanek; Amy Lewis; Patrick B Murphy; Nicholas Hart; John Moxham; Hugh E Montgomery; Paul R Kemp; Michael I Polkey; Nicholas S Hopkinson
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

Review 10.  ALUminating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for Alu Repeats in the Development of Atherosclerotic Vascular Disease.

Authors:  Miguel Hueso; Josep M Cruzado; Joan Torras; Estanislao Navarro
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.